Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

Loss of autoantibody activity by alteration in autoantigen.

Spitzer RE, Stitzel AE.

Clin Immunol Immunopathol. 1996 Aug;80(2):211-3.

PMID:
8764567
2.

Nucleotide sequence of a human autoantibody to the alternative pathway C3/C5 convertase (C3NeF).

Victor KD, Pascual V, Stitzel AE, Tsokos GC, Capra JD, Spitzer RE.

Hybridoma. 1993 Jun;12(3):231-7.

PMID:
8395463
3.
4.

Long-term follow-up of non-systemic lupus erythematosus glomerulonephritis in patients with hereditary angioedema: report of four cases.

Pan CG, Strife CF, Ward MK, Spitzer RE, McAdams AJ.

Am J Kidney Dis. 1992 Jun;19(6):526-31.

PMID:
1595700
6.

Autoantibody to the alternative pathway C3/C5 convertase and its anti-idiotypic response. A study in affinity.

Spitzer RE, Stitzel AE, Tsokos GC.

J Immunol. 1992 Jan 1;148(1):137-41.

PMID:
1727863
7.

Human anti-idiotypic antibody responses to autoantibody against the alternative pathway C3 convertase.

Spitzer RE, Stitzel AE, Tsokos GC.

Clin Immunol Immunopathol. 1990 Oct;57(1):19-31.

PMID:
2394034
9.
10.

Human polyclonal and monoclonal IgG and IgM complement 3 nephritic factors: evidence for idiotypic commonality.

Tsokos GC, Stitzel AE, Patel AD, Hiramatsu M, Balow JE, Spitzer RE.

Clin Immunol Immunopathol. 1989 Oct;53(1):113-22.

PMID:
2475285
11.

On the origin and control of C3NeF.

Spitzer RE, Stitzel AE.

In Vivo. 1988 Jan-Feb;2(1):79-81. Review.

PMID:
2979821
12.

Sonography of the kidneys in hemolytic uremic syndrome.

Kenney PJ, Brinsko RE, Patel DV, Spitzer RE, Farrar FM.

Invest Radiol. 1986 Jul;21(7):547-50.

PMID:
3525450
13.

Components of the alternative pathway of complement in otitis media with effusion.

Parker MJ, Leopold DA, Stitzel AE, Welch TR, Weiner LB, Spitzer RE.

Otolaryngol Head Neck Surg. 1985 Oct;93(5):607-11.

PMID:
2932669
14.

Prostanoids in hemolytic uremic syndrome.

Stuart MJ, Spitzer RE, Walenga RW, Boone S.

J Pediatr. 1985 Jun;106(6):936-9. No abstract available.

PMID:
3839015
15.

An abnormality of the fourth component of complement associated with benign recurrent hematuria.

Welch TR, Stitzel AE, Spitzer RE.

Nephron. 1984;38(2):138-43.

PMID:
6472541
16.

Altered bicarbonate reabsorption in the pancreas of reserpine-treated rabbits--a model for cystic fibrosis.

Shiffman ML, Spitzer RE, Swender PT, Galey WR.

Pediatr Res. 1983 Jun;17(6):486-90. No abstract available.

PMID:
6877902
17.

Abnormal platelet and vascular prostaglandin synthesis in an infant with hemolytic uremic syndrome.

Stuart MJ, Spitzer RE, Coppe D.

Pediatrics. 1983 Jan;71(1):120-4. No abstract available.

PMID:
6336835
18.

Inflammatory bowel disease, psoriasis, and complement.

Rosenberg EW, Spitzer RE, Marley WM, Belew PW.

N Engl J Med. 1982 Sep 9;307(11):685-6. No abstract available.

PMID:
7110219
19.

Abnormalities in the alternative pathway of complement in psoriasis.

Marley WM, Belew PW, Rosenberg EW, Urmson JR, Stitzel AE, Spitzer RE.

Clin Exp Dermatol. 1982 Jul;7(4):387-96. No abstract available.

PMID:
7127887
20.

Decreased chemotactic activity in activated newborn plasma.

Tannous R, Spitzer RE, Clarke WR, Goplerud CP, Cavendar-Zylich N.

J Lab Clin Med. 1982 Mar;99(3):331-41.

PMID:
7057060
21.

Evaluation of Streptococcus pneumoniae type XIV opsonins by phagocytosis-associated chemiluminescence and a bactericidal assay.

Gardner SE, Anderson DC, Webb BJ, Stitzel AE, Edwards MS, Spitzer RE, Baker CJ.

Infect Immun. 1982 Mar;35(3):800-8.

22.

Complement changes during granulocyte adhesion.

Strauss RG, Spitzer RE, Stitzel AE, Urmson JR.

Transfusion. 1981 Nov-Dec;21(6):693-8.

PMID:
6797111
23.

Nephrotic syndrome: increased platelet prostaglandin endoperoxide formation, hyperaggregability, and reduced platelet life span. Reversal following remission.

Stuart MJ, Spitzer RE, Nelson DA, Sills RH.

Pediatr Res. 1980 Sep;14(9):1078-81. No abstract available.

PMID:
7454449
24.

Alteration of the complement system in children with acquired thyroid disease.

Richman RA, Urmson JR, Dickson SL, Farnett ML, Stitzel AE, Spitzer RE.

Clin Immunol Immunopathol. 1980 Apr;15(4):600-6. No abstract available.

PMID:
7357761
25.

Characterization of a C3/C3b regulatory protein in normal human serum.

Spitzer RE, Stitzel AE, Hoffman GL.

J Pediatr. 1980 Mar;96(3 Pt 2):564-8.

PMID:
7359260
26.

Hereditary angioneurotic edema: immunochemical 'activity' without clinical expression.

Spitzer RE, Stitzel AE, Urmson JR.

Int Arch Allergy Appl Immunol. 1980;61(3):286-92.

PMID:
6965489
27.

Complement changes during leukapheresis.

Strauss RG, Spitzer RE, Stitzel AE, Urmson JR, Maguire LC, Koepke JA, Thompson JS.

Transfusion. 1980 Jan-Feb;20(1):32-8. No abstract available.

PMID:
6898377
28.

Complement alterations in inflammatory bowel disease.

Lake AM, Stitzel AE, Urmson JR, Walker WA, Spitzer RE.

Gastroenterology. 1979 Jun;76(6):1374-9.

PMID:
437435
29.

Antibody and complement-mediated cytotoxicity of nucleated cells. Inhibition by the sera of patients with acute lymphoblastic leukemia.

Bock GH, Stitzel AE, Rittenhouse KW, Spitzer RE.

Transplantation. 1978 Dec;26(6):415-9. No abstract available.

PMID:
282705
30.

Alteration of the complement system in children with Henoch Schönlein purpura.

Spitzer RE, Urmson JR, Farnett ML, Stitzel AE, Post EM.

Clin Immunol Immunopathol. 1978 Sep;11(1):52-9. No abstract available.

PMID:
699388
31.

Is glomerulonephritis after bacterial sepsis always benign?

Spitzer RE, Stitzel AE, Urmson JR.

Lancet. 1978 Apr 22;1(8069):871. No abstract available.

PMID:
76811
32.

The complement system: a cascade foreboding and unharnessed whose waters run deep.

Spitzer RE.

Pediatr Clin North Am. 1977 May;24(2):341-64. Review. No abstract available.

PMID:
323804
33.

Immunobiology and clinical importance of the complement system of man.

Spitzer RE.

Adv Pediatr. 1977;24:43-101. Review. No abstract available.

PMID:
341668
34.

Activation of the alternative pathway of complement in childhood acute lymphoblastic leukemia.

Kalwinsky DK, Urmson JR, Stitzel AE, Spitzer RE.

J Lab Clin Med. 1976 Nov;88(5):745-56.

PMID:
1068203
35.

46,XY/46,XY,21q- mosaicism in an infant with neutropenia and properdin deficiency.

Neu RL, Stockman JA, Spitzer RE, Tomar RH.

J Med Genet. 1976 Aug;13(4):332-4.

36.

Interaction of properdin convertase and properdin in the alternative pathway of complement activation.

Spitzer RE, Stitzel AE, Urmson J.

Immunochemistry. 1976 Jan;13(1):15-20. No abstract available.

PMID:
943370
37.

Letter: C3 standards.

Stitzel AE, Spitzer RE.

Lancet. 1975 Aug 23;2(7930):364. No abstract available.

PMID:
51166
38.
39.

The utilization of properdin in the alternate pathway of complement activation: isolation of properdin convertase.

Stitzel AE, Spitzer RE.

J Immunol. 1974 Jan;112(1):56-62. No abstract available.

PMID:
4130153
40.

Complement inhibition after canine and human renal allotransplantation.

Spitzer RE, Bell MJ, Stitzel AE, Pauling V, McEnery P.

Ann Surg. 1973 Dec;178(6):791-9. No abstract available.

41.

The natural history of membranoproliferative glomerulonephritis: its relation to the hypocomplementemia.

West CD, Ruley EJ, Spitzer RE, Davis NC.

Perspect Nephrol Hypertens. 1973;1 Pt 1:531-40. Review. No abstract available.

PMID:
4620926
42.

Detection and treatment of canine cardiac rejection.

Benzing G 3rd, Spitzer RE, Bove KE, Schreiber JT, Helmsworth JA.

Transplantation. 1972 Jul;14(1):35-40. No abstract available.

PMID:
4556401
43.

Inhibition of C3 conversion after allotransplantation.

Spitzer RE, Stitzel AE.

Transplantation. 1972 Feb;13(2):116-26. No abstract available.

PMID:
4550986
44.

Immunochemical measurement of the inhibition of C3 conversion after allotransplantation.

Spitzer RE, Stitzel AE.

Transplantation. 1972 Feb;13(2):111-5. No abstract available.

PMID:
4550985
45.
46.

Continuing C3 breakdown after bilateral nephrectomy in patients with membrano-proliferative glomerulonephritis.

Vallota EH, Forristal J, Spitzer RE, Davis NC, West CD.

J Clin Invest. 1971 Mar;50(3):552-8.

47.

Deviations in the complement system and chronic glomerulonephritis.

West CD, Spitzer RE.

J Pediatr. 1971 Jan;78(1):191-3. No abstract available.

PMID:
5539082
48.

Characteristics of a non-complement-dependent C3-reactive complex formed form factors in nephritic and normal serum.

Vallota EH, Forristal J, Spitzer RE, Davis NC, West CD.

J Exp Med. 1970 Jun 1;131(6):1306-24.

49.

Serum C'3 lytic system in patients with glomerulonephritis.

Spitzer RE, Vallota EH, Forristal J, Sudora E, Stitzel A, Davis NC, West CD.

Science. 1969 Apr 25;164(3878):436-7.

PMID:
4180576

Supplemental Content

Loading ...
Support Center